Skip to main content
OpenTrials
Completed

NCT Number: NCT07200960

ESP vs Retrolaminar Block: A Randomized Trial

The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Shaukat Khanum Memorial Cancer Hospital & Research Centre.

Lahore, Punjab Province, Pakistan

About this study

The study aims to compare the efficacy in pain control and total opioid consumption after the use of ESPB and retrolaminar block in patients undergoing major oncological breast surgery..

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female patients between 18- 60 years ASA 1 and 2

Exclusion criteria

  • Patient refusal Allergic reaction infection emergency case BMI >35

Treatment and study plan

ESPB

Procedure

Patient receiving ESPB for major oncological breast surgery Patient receiving Retrolaminar Block for major oncological breast surgery

Other names: Retrolaminar Block

Primary outcomes

  1. Comparison of pain score of patients receiving ESPB and retrolaminar block

    Time frame: 2hours post surgery

    Numeric rating scale score

Secondary outcomes

  1. Comparison of total opioid consumption in 24 hours of patients receiving ESPB and retrolaminar block

    Time frame: 24 hours post surgery

    total consumption of opioids in MG

Sponsors and collaborators

Lead sponsor

Shaukat Khanum Memorial Cancer Hospital & Research Centre

Other

Registry information

Official study title

Analgesic Efficacy of Erector Spinae Plane Block Versus Retrolaminar Block in Patients Undergoing Major Oncological Breast Surgery: a Randomized Controllled Trial

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Oct 1, 2025
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.